Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Price dropping on high volume is not a good sign. Selling is taking place and has been taking place. Tax loss selling already in effect.
Poor time to buy.
Horrible investment
$2.47 SP says not many believe it is going to be successful. So if evidence is there, Why have a trial?
All BS.
Show me the link stating the AD trial will be successful?
More trials and larger trials might be needed.
“any future dilution””
Is stating NO more dilution. More dilution is on the way at $7m per qtr despite all of this free money from Aussie.
Fire king and queen of the Anavex Misleading team.
Anavex pumps, promises, partnerships, and little progress.
Market forecast SP will drop more per technicals..
Also $2.50 put open.
11/15 OI 680
12/20 OI 230. I repeat 230
1/17 OI 3,325
More interest in November than December at about 3x and Jan at 3,325. 12/20 has BE at $2.15 as of today.
Looks like market prediction is no great news and price can go lower from here. Tax loss selling in December on tap. Only 230 in December.
Market is not always right but it’s not favorable.
Your statement implies no more dilution so your reply is non sensical or logical..
My reply to,
1st your reply doesnt really make a lot of sense, and is purely conjecture as to any future dilution and/or reverse split.
2nd what is your solution in funding a new company if it's not through share issuance?
3rd what do you feel is a proper limit to the number of shares to issue if it's not 50 million?
Share price was not $14 last week. Last week was not the context of the discussion. When good news comes out, the dilution will bring the price right back down to a lower level.
Pretty much since Reverse split we’ve had lower highs and lower lows at Dec 2018. It will be interesting to see if we dip below $2.00 again and how low we go..
$250M weight will keep SP down.
New concept. Conclude a trial on time and move forward. New concept give enrollment update every quarter.
It’s not like 52 million is the end. $250m shelf is open. I guess misleading opened this shelf and he has no plans to use it. Try adding 50 to 100 million more shares. Look at history in 2014 to 2015 added 40 million shares in one year then in fall 2015 reverse split.
Reverse split on tap.
Pretty obvious millions of shares were diluted. It’s all in the 10k.
Costs, are the point. Resources are the point. Moving forward is the point. SOC did not take this route and FDA or other agencies do not require it. It’s wasteful. Conduct clinical and move forward.
That was pre reverse split. Misleading will wait for a little good news and hope SP increases and dilute the high heavens with shares again.
What happened when $SP got to $14.. Diluted all the way back down to $3. History or man will repeat, rinse and recycle..
It’s always a positive sign when companies provide information at the start and later conceal information from shareholders and their employees. LOL
Reply to
The SP doesn’t bother me. What is starting to make me more than a little concerned, is why haven’t They PR’ed full enrollment on any of the trials?
Many weeks ago M stated that we were very close and that they would PR full enrollment.
What gives Doc??
Just 4 years ago they had 120M shares outstanding per 10Q.
Remember they diluted 40M shares in like 2014. And now $250M shelf on standby.
For the quarterly period ended: June 30, 2015
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
120,446,116 shares of common stock outstanding as of August 14, 2015.
No debt right.
https://fintel.io/so/us/avxl
I pulled from Fintel while looking at tute ownership.
Nice graphic which illustrates the reality of all this wasteful spend on extensions. Instead of extension how about conclude a trial on time and move forward. New concept
Over 52 million shares diluted as of 6/30 and now with all of these extension on trials, expect that number to multiple exponentially.
Share price the same 10 years ago and how much money in opportunity costs has been loss. Thousands.
Volume up share price down equals dilution. Not enough demand to keep up with dilution equals more road shows. Keep paying people to write articles. Keep promising retail to keep interested. Add Drs that want a paycheck to appear progress is being made. Repeat repeat repeat.
2-73 the expensive sleeping pill. That’s the MOA.
End result is the same. He did not make the purchase and I bet he will not make that mistake again by discussing planned purchases in a non public setting. CEO purchases are value drivers and he cannot disclose to an individual on the street prior to event.
It goes on to say
hear·say
/'hir?sa/
Learn to pronounce
noun
information received from other people that one cannot adequately substantiate; rumor.
"according to hearsay, Bob had managed to break his arm"
the report of another person's words by a witness, which is usually disallowed as evidence in a court of law.
"everything they had told him would have been ruled out as hearsay"
Thank you.
It’s not technically hearsay as I was using your terms. It’s only hearsay if someone is trying to use information from other people that one cannot substantiate primarily in a court setting.
Again this is a complaint which is not a court.
Again he has not made a purchase or made a statement to anyone outside a public venue.
I believe we call that a complaint and hence that was just one of the complaints we submitted going back to his last set of purchases. Note he has not made any comments since or purchases for that matter.
Complaints can stem from hearsay and hence an investigation.
If prosecution has to arise from clear and convincing evidence, there would be no need for investigations or trials.
impeachment Investigation as an example?
It only requires an inquiry and multiple help.
He can make purchases but if he telegraphs them in a non public venue, he is dumber than he sounds.
Greed the root of all evil.
I didn’t say AVXL was a scam today. Chris M. Questionable character hence the complaints and modus operandi changed. Recall comment from investor meeting stating to an individual that he was getting ready to buy boatloads more stock. Needless to say he didn’t buy any since.
We made sure to silence him on those statements. He has not made a statement about buying stock to an individual since.
Questionable hell yes.
Trifecta July 2019. I meant the next July 2019. You’ll see trifecta July 2019. Anavex at all costs. You’ll see July 2019. Just wait.
HH left for the money despite 2-73 being the best thing since government cheese. Appears Aisen and HH both support Amyloid. 2-73 rocks.
Reply to
Aisen gets money from Big Pharma to run his programs. Can't diss the people with the open wallets
The best CEOs keep their shareholders in the dark and withhold information. YES that’s the best leader. Chris M is the best CEO and he never makes missteps. He’s like the big man above.
All trials 100% enrolled and that’s why we did not disclose enrollment figures.
Everyone’s profit is what 100% this year, congrats to all longs.
Anavex rocks.
More $1.25 shares on the way? Everyone’s cost basis is $1.25 so there will be no tax loss selling even though trades took place above $1.25 99% of the year.
Excessive dilution is the only guarantee.
This stock is not going to get a provisional approval.
Fire Missling.
This company has presented data at more conferences than any other company I’m invested in. We will agree to disagree. IMO they are known and other tutes agree to not invest. The risk to own and the opportunity costs too great.. making money is the name of the game and holding this company for years has not yielded a profit above the SP 500 for me.
Trading and options is the only way. I’m looking forward to the next pump. Retail will buy out of the money options at a premium.
SP will continue to lag even if results are above par. Market has no confidence in CEO. History of missed timelines, delays and waste. This OJT is too costly for most hence tutes ownership not much higher than insider ownership. Dead money and has been for years. Share price was $3 bucks ten years ago. Trend is the same, dilute and over promise.
Anavex stock still garbage.
Missling is somewhere working on his next lie. Next pump. Next missed timeline. Next softball endpoint. Next dilution deal. Next 375 share purchase. Next worthless board member.
Stock garbage in 2019 and will be in 2020.
Misleading Missling does not have a master plan. If so it’s full of errors and misleading timelines. Fire Missleading.
I’m going to say this post below yours is claiming it.
It states
Yes, I said as far as we know at this time 2-73 will treat 100% but 20% may not respond as well.
Ridiculous
Back burner yes